Goldman Sachs’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-70,113
Closed -$238K 4379
2018
Q3
$238K Sell
70,113
-50,425
-42% -$171K ﹤0.01% 3752
2018
Q2
$453K Sell
120,538
-723,460
-86% -$2.72M ﹤0.01% 3568
2018
Q1
$3.45M Buy
843,998
+154,575
+22% +$632K ﹤0.01% 2555
2017
Q4
$3.21M Sell
689,423
-18,630
-3% -$86.6K ﹤0.01% 2555
2017
Q3
$5.03M Buy
708,053
+22,380
+3% +$159K ﹤0.01% 2347
2017
Q2
$4.96M Buy
685,673
+7,211
+1% +$52.1K ﹤0.01% 2286
2017
Q1
$4.18M Buy
678,462
+22,388
+3% +$138K ﹤0.01% 2303
2016
Q4
$3.85M Buy
656,074
+37,554
+6% +$220K ﹤0.01% 2334
2016
Q3
$3.28M Buy
618,520
+186,758
+43% +$992K ﹤0.01% 2453
2016
Q2
$2.86M Buy
431,762
+361,929
+518% +$2.4M ﹤0.01% 2422
2016
Q1
$326K Buy
69,833
+3,362
+5% +$15.7K ﹤0.01% 3492
2015
Q4
$336K Sell
66,471
-1,079,058
-94% -$5.45M ﹤0.01% 3459
2015
Q3
$4.03M Buy
1,145,529
+1,027,323
+869% +$3.62M ﹤0.01% 2136
2015
Q2
$1.18M Buy
118,206
+83,068
+236% +$829K ﹤0.01% 2867
2015
Q1
$447K Sell
35,138
-29,647
-46% -$377K ﹤0.01% 3388
2014
Q4
$917K Sell
64,785
-101,011
-61% -$1.43M ﹤0.01% 2986
2014
Q3
$2.28M Buy
165,796
+2,201
+1% +$30.3K ﹤0.01% 2447
2014
Q2
$2.52M Buy
163,595
+112,360
+219% +$1.73M ﹤0.01% 2405
2014
Q1
$873K Sell
51,235
-514,373
-91% -$8.76M ﹤0.01% 3077
2013
Q4
$7.33M Sell
565,608
-200,950
-26% -$2.6M ﹤0.01% 1742
2013
Q3
$7.74M Buy
766,558
+231,868
+43% +$2.34M ﹤0.01% 1637
2013
Q2
$3.99M Buy
+534,690
New +$3.99M ﹤0.01% 1899